Toxic epidermal necrolysis (SCORTEN score) is a rare, acute, and life-threatening mucocutaneous disease characterized by extensive epidermal detachment and necrosis, predominantly induced by adverse drug reactions 1, 2. Recognized as the severe end of the Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) spectrum—now collectively termed epidermal necrolysis (EN)—TEN involves greater than 30% of the total body surface area (BSA) 6, 7. The pathophysiology involves widespread keratinocyte apoptosis mediated by cytotoxic T lymphocytes and natural killer cells via pathways including granulysin, perforin-granzyme, and Fas-FasL interactions 2, 7. Management requires emergency transfer to an intensive care unit or specialized burn unit, immediate cessation of all non-essential medications, meticulous supportive care, and consideration of immunomodulatory agents 4, 5.

1. Etiology & Risk Factors

  • High-Risk Pharmacological Agents: Most cases are drug-induced, typically occurring 1 to 3 weeks after initiating the culprit agent. Common high-risk drugs include aromatic anticonvulsants (carbamazepine, phenytoin, lamotrigine), allopurinol, antibacterial sulfonamides, oxicam non-steroidal anti-inflammatory drugs (NSAIDs), and nevirapine 2, 3.
  • Genetic Predispositions: Strong pharmacogenomic associations exist, notably HLA-B*58:01 for allopurinol-induced TEN, HLA-B*15:02 for carbamazepine-induced TEN in specific Asian populations, and HLA-A*31:01 for carbamazepine hypersensitivity in European cohorts 3, 7.
  • Host and Immunological Risk Factors: Immunocompromised states (such as HIV infection, active malignancies, and systemic autoimmune disorders) significantly increase susceptibility and alter baseline prognostic risk 3, 5.
  • Idiopathic and Infection-Triggered Cases: While predominantly drug-related, a subset of cases are associated with Mycoplasma pneumoniae infections, viral triggers, or are strictly idiopathic 2, 4.

2. Pathophysiology

The pathogenesis of toxic epidermal necrolysis represents a delayed-type hypersensitivity (Type IV) reaction characterized by extensive immune-mediated apoptosis of epidermal keratinocytes. Drug-specific CD8+ T-lymphocytes and natural killer (NK) cells are activated and traffic into the skin, releasing high concentrations of cytotoxic mediators including granulysin, perforin, granzyme B, and soluble Fas ligand (FasL) 2, 7. Granulysin acts as the primary lethal effector molecule responsible for widespread keratinocyte cell death 2, 7. The binding of FasL on cytotoxic cells to Fas receptors on keratinocytes triggers an intracellular apoptotic cascade involving caspase activation. This massive apoptotic destruction leads to cleavage at the dermo-epidermal junction, resulting in subepidermal blistering, frank epidermal detachment, and full-thickness cutaneous sloughing 4, 6.

Toxic epidermal necrolysis (SCORTEN score) — Pathophysiological Cascade & Clinical Flowchart 1 Trigger / Primary Insult Exposure to culprit medication (e.g., allopurinol, antiepileptics) triggering aberrant CD8+ T-cell and granulysin-mediated keratinocyte apoptosis 2 Cellular / Pathophysiological Cascade Massive Fas-FasL interactions, perforin/granzyme B release, and widespread full-thickness epidermal necrosis 3 Target Organ / Structural Change Dermal-epidermal junction separation leading to widespread skin sloughing and severe hemorrhagic mucosal erosions 4 Hallmark Clinical & Diagnostic Manifestation Positive Nikolsky sign, extensive BSA detachment (>30%), and multi-organ systemic compromise 5 Complications if Untreated & Therapeutic Target High risk of sepsis, multi-organ failure, and death; mitigated by immediate drug cessation, ICU/burn unit care, and immunomodulatory therapy

3. Clinical Presentation & Classic Clinical Signs

  • History & Cardinal Symptoms: Patients typically present with a 1-to-3-day prodrome of high fever, malaise, arthralgias, and stinging ocular pain before cutaneous manifestations appear 2, 3. This is followed by the acute onset of cutaneous burning and tenderness, often out of proportion to initial visible findings 3, 4.
  • Physical Examination & Named Clinical Signs: Examination reveals widespread, coalescing erythematous or dusky purpuric macules with atypical targets, rapidly evolving into flaccid blisters and extensive sheets of epidermal sloughing 2, 4. A positive Nikolsky sign—shearing of the epidermis upon lateral digital pressure on apparently normal skin—is a hallmark clinical indicator of epidermal detachment 1, 2. Asboe-Hansen sign (extension of blister fluid into adjacent skin upon direct pressure) may also be demonstrated 2, 4.
  • Mucosal Involvement: Haemorrhagic erosions and painful ulcerations affect at least two mucosal surfaces in over 90% of patients, frequently involving the oral cavity, ocular conjunctivae, and urogenital mucosa, leading to severe functional compromise and long-term sequelae 4, 5, 6.

4. Diagnostic Workup & Interpretation (Laboratory, Imaging & ECG/Pathology)

Diagnostic Modality / Test Expected Clinical & Radiological / Laboratory Finding
Gold-Standard InvestigationSkin biopsy (frozen or paraffin-embedded section) demonstrating full-thickness epidermal keratinocyte necrosis, subepidermal split, and minimal inflammatory cell infiltrate in the dermis 2, 6.
Laboratory PanelComplete Blood Count (CBC) revealing marked leukopenia or anemia; elevated inflammatory markers (CRP, ESR); electrolyte derangements secondary to extensive transcutaneous fluid loss (hyponatremia, hypokalemia, hypomagnesemia); and elevated BUN/creatinine indicating prerenal azotemia or acute kidney injury 3, 5.
Imaging / Radiology (X-ray, US, CT, MRI)Chest radiography or high-resolution CT chest to monitor for non-cardiogenic pulmonary edema, pneumonitis, or secondary lower respiratory tract infections/bronchiectasis resulting from bronchial mucosal sloughing 4, 5.
ECG / Histopathology / Procedural12-lead ECG to baseline cardiac conduction before systemic therapies; direct inspection of mucosal surfaces via upper endoscopy or bronchoscopy if gastrointestinal or pulmonary mucosal sloughing is suspected 5, 6.

5. Staging, Classification & Clinical Scoring Systems

Criterion / Stage / Score Component Clinical Threshold, Points & Management Implication
BSA Detachment ClassificationSJS (<10% BSA); SJS-TEN overlap (10–30% BSA); TEN (>30% BSA). Guides immediate triage to burn unit versus standard ward 2, 6.
SCORTEN Age FactorAge > 40 years = 1 point. Predicts heightened baseline mortality risk 1.
SCORTEN MalignancyPresence of underlying active malignancy = 1 point 1.
SCORTEN Tachycardia & AzotemiaHeart rate > 120 bpm = 1 point; Serum urea > 10 mmol/L (28 mg/dL) = 1 point 1.
SCORTEN Initial DetachmentInitial epidermal detachment > 10% BSA = 1 point 1.
SCORTEN Bicarbonate & GlucoseSerum bicarbonate < 20 mmol/L = 1 point; Serum glucose > 14 mmol/L (250 mg/dL) = 1 point 1. Total score 0–1 (<3% mortality); score 2 (~12%); score 3 (~35%); score 4 (~58%); score ≥5 (>90% mortality) 1.

6. Differential Diagnosis

Differential Condition Distinguishing Clinical, Biochemical & Imaging Features
Staphylococcal Scalded Skin Syndrome (SSSS)Predominantly affects infants and young children; mediated by epidermolytic toxins A and B cleaving desmoglein-1 in the superficial epidermis (intraepidermal split); mucous membranes are characteristically spared; Nikolsky sign is positive 2, 4.
Erythema Multiforme MajorCharacterized by classic target lesions with well-defined concentric rings (iris lesions), typically acral distribution, often triggered by Herpes Simplex Virus (HSV) rather than drugs, with limited mucosal involvement and minimal skin detachment (<10%) 3, 6.
Generalized Bullous Fixed Drug Eruption (GBFDE)Presents with sharply demarcated, dusky erythematous or violaceous patches that recur in the exact same anatomical location upon re-exposure to the drug; lacks the extensive prodromal systemic symptoms and severe diffuse mucosal involvement of TEN 4, 7.
Acute Generalized Exanthematous Pustulosis (AGEP)Characterized by the rapid eruption of numerous non-follicular sterile subcorneal pustules on an edematous erythematous base, accompanied by fever and leukocytosis; histopathology shows intraepidermal pustules rather than full-thickness epidermal necrosis 2, 5.

7. Management & Treatment Protocol

  • Initial Stabilization & Resuscitation: Immediate transfer to an Intensive Care Unit (ICU) or specialized Burns Unit is mandatory. Prompt withdrawal and elimination of all suspect culprit medications is the single most critical intervention influencing survival 4, 5. Maintain ambient room warmth (30–32°C) to prevent hypothermia due to loss of skin barrier function 4.
  • Supportive Care Protocols: Aggressive fluid resuscitation calculated via modified burn formulas (tailored carefully to avoid fluid overload and pulmonary edema), nutritional support via nasogastric tube to maintain hypermetabolic state, meticulous electrolyte monitoring, and strict aseptic wound care 4, 5. Non-adherent silicone or lipidocolloid dressings are utilized to minimize shear forces and prevent secondary infection 4.
  • First-Line Medical & Immunomodulatory Therapy: While supportive care remains foundational, immunomodulatory agents are widely utilized based on expert consensus and observational data 2, 5, 6. Cyclosporine (3–5 mg/kg/day) has demonstrated efficacy in halting disease progression by inhibiting cytotoxic T-cell activation 2, 5. Systemic corticosteroids are utilized selectively, though regimens combining IVIG and corticosteroids or anti-TNF-alpha agents (e.g., etanercept) remain subjects of ongoing clinical trials and institutional protocols 2, 5, 7.
  • Multidisciplinary Specialist Consultations: Urgent ophthalmology evaluation is required within 24 hours for daily assessment, lysis of symblephara, and application of preservative-free lubricants and topical amniotic membrane transplantation or steroid drops 4, 5. Dermatology, urology, gynecology, and physical therapy consults are essential to manage mucosal erosions and prevent long-term joint and soft-tissue contractures 4, 5.

8. Complications & Prognosis

  • Acute Complications: Sepsis and septic shock (frequently caused by Staphylococcus aureus or Pseudomonas aeruginosa), fluid and electrolyte imbalance, acute respiratory distress syndrome (ARDS), multi-organ dysfunction syndrome (MODS), and gastrointestinal bleeding 3, 4.
  • Long-Term Sequelae: Ocular complications occur in up to 50–80% of survivors, including dry eye syndrome, trichiasis, symblepharon, corneal scarring, and permanent visual impairment 4, 5. Cutaneous sequelae include pigmentary abnormalities, scarring, nail dystrophy, and eruptive nevi 5. Gynecological adhesions and urethral strictures frequently develop in mucosal surfaces 4, 5. Psychological morbidity, including post-traumatic stress disorder (PTSD) and depression, is prevalent 5.
  • Prognosis & Mortality: Despite specialized intensive care, overall mortality in TEN ranges from 20% to 30%, primarily driven by advanced age, extent of epidermal detachment, and comorbidities as quantified by the SCORTEN prognostic model 1, 3.